CE mark of rtx1 extended to new features

15.11.2024

We are pleased to announce that we have successfully extended the scope of CE certification for the rtx1 AO retinal camera to the new AOimage 3.7 software, which opens a new range of possibilities for investigating retinal diseases and therapies.

In response to invaluable feedback from rtx1 users, we have incorporated several time-saving features that streamline retinal examinations at the cellular level, and standardize AO imaging procedures to facilitate its implementation in clinical studies and trials.

With this evolution, the rtx1 device not only simplifies the use of AO imaging, but also introduces new imaging capabilities for deeper investigation of retinal phenotypes.

The door is open to new advances and discoveries !

rtx1 device assesses retinal vessels, photoreceptor and RPE cells

Discover the rtx1 AO camera

What’s new in rtx1 with AOimage 3.7

STREAMLINE

the use of AO in clinical trial protocols

Protocol workflows

guide rtx1 users though predefined, expandable SOPs

1 2

Fast follow-up workflow

reproduces all the condtions of the baseline AO exam

Foveal sparing in RP, visit 1
Foveal sparing in RP, visit 1
Foveal sparing in RP, visit 1
Foveal sparing in RP, visit 2
Foveal sparing in RP, visit 2
Foveal sparing in RP, visit 2
Foveal sparing in RP, visit 3
Foveal sparing in RP, visit 3
Foveal sparing in RP, visit 3

Integrated auto-montage

1 2

For rtx1-TFI model only

Hybrid Photoreceptor/RPE capture

EXTEND

AO for new explorations and discoveries

Gaze-dependent imaging

to investigate phenotypes involving small drusen*

*Rossi et al. Trans. Vis. Sci. Tech. 10, 19 (2021)

Pupil-dependent imaging

to investigate cone misalignment in pathology**

Msaligned cones after reattachment - Paques et al - 2

**Paques et al. Retina 10.1097 (2020)

Flicker stimulation

to explore light-induced response of small retinal vessels

More about the rtx1 AO camera Published clinical research

rtx1 is a certified medical device of class IIa in the European Union. rtx1 is an approved medical device in Japan, China and South Korea. In the USA, rtx1 has not received FDA clearance; it is an investigational device that requires Institutional Review Board (IRB) oversight. For use by trained eyecare professionals only.

The contents of this webpage may differ from the curent state of approval of the product in your country. Please contact Imagine Eyes or your local representative for more information.